Release Date: 05/05/15 13:07 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 295.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%